Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Daily Scalp Care, Redefined
additive with GLP-1 Semaglutide Established CV outcomes Tirzepatide Highest single-agent obesity efficacy Retatrutide Triple-agonist mechanism Numbers reflect published Phase 3 endpoints where available
Skin, hair, healing, and recovery, with the strongest evidence on the skin and the most hype around injectables
If symptoms persist, consult your healthcare professional
Retatrutide shows potentially superior weight loss numbers but remains investigational, with Phase 3 trials still underway
US$ 21.95
US$ 25.03
US$ 28.65
